ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01115322
Recruitment Status : Completed
First Posted : May 4, 2010
Last Update Posted : June 20, 2017
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
GlaxoSmithKline ( Stiefel, a GSK Company )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 10, 2010
  Actual Study Completion Date : April 10, 2010
Publications:
Daniel Hogan, Alessandra Alio. Phototoxic and Photoallergic Potential of Tazarotene Foam, 0.1% in 2 Vehicle-Controlled Phase 1 Patch Studies (W0260-103 & W0260-104). Cutis. 2012;(November):